RTP-based BioMedomics seeks FDA OK for ’emergency use’ of its coronavirus test
The company has developed a new test for rapidly detecting COVID-19, the coronavirus infection that is spreading rapidly throughout the world.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
